Piramal Pharma Limited has announced its commitment to reduce greenhouse gas emissions, which has been validated by the Science Based Targets initiative. This makes Piramal Pharma the third global pharmaceutical company in India to receive such validation from SBTi. The announcement emphasizes the company's dedication to sustainability and aligns with its business strategies.
Piramal Pharma Limited has informed the Exchange regarding a press release dated September 17, 2024, titled "Press Release Piramal Pharma Limited ( the Company ) commitment to reduce Greenhouse Gas (GHG) emissions, validated and approved by Science Based Targets initiative (SBTi)".